Tumor cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer drugs. In some types of the disease, such as certain forms of lung cancer, this state is triggered by stress hormones in the ...
Jun 15, 2026
0
8
Researchers have discovered a new way that brain plasticity is controlled in early life, offering insight into the little-understood phenomenon of critical-period closure. In the months or years after birth, critical periods ...
May 31, 2026
0
36
When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ways that blunt immune response, according to new research led by UT Southwestern Medical Center. ...
May 22, 2026
0
10
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...
May 12, 2026
0
6
Stress, the body's natural response to different types of challenges and daily problems, is an inherently harmless state experienced by most people worldwide. While short-term stress is a common experience and can even be ...
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel, Switzerland, have now discovered that it also fights metastases ...
Nov 24, 2025
0
19
Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more selective drugs. These new drugs could modulate this association and thus minimize serious adverse ...
Oct 27, 2025
0
11
Why do some people remain healthy through childhood yet become more vulnerable to brain disorders such as dementia later in life? A KAIST-led team has uncovered a key part of the answer: a developmental "switch" in astrocytes—the ...
Sep 25, 2025
0
176
Diabetic foot ulcers (DFUs) are a major clinical challenge, with high rates of morbidity, disability, amputations and mortality. Despite extensive research, effective predictive biomarkers for DFUs healing remain elusive.
Jun 13, 2025
0
21
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.
Jun 10, 2025
0
16
